Ginete Catarina, Delgadinho Mariana, Santos Brígida, Miranda Armandina, Silva Carina, Guerreiro Paulo, Chimusa Emile R, Brito Miguel
H&TRC-Health & Technology Research Center, ESTeSL-Escola Superior de Tecnologia da Saúde, Instituto Politécnico de Lisboa, 1990-096 Lisbon, Portugal.
Centro de Investigação em Saúde de Angola (CISA), Bengo 9999, Angola.
Genes (Basel). 2024 Apr 8;15(4):469. doi: 10.3390/genes15040469.
The aim of this study was to identify genetic markers in the Cluster; intergenic region; and , , , and genes associated with the heterogeneous phenotypes of Sickle Cell Anemia (SCA) using next-generation sequencing, as well as to assess their influence and prevalence in an Angolan population. Hematological, biochemical, and clinical data were considered to determine patients' severity phenotypes. Samples from 192 patients were sequenced, and 5,019,378 variants of high quality were registered. A catalog of candidate modifier genes that clustered in pathophysiological pathways important for SCA was generated, and candidate genes associated with increasing vaso-occlusive crises (VOC) and with lower fetal hemoglobin (HbF) were identified. These data support the polygenic view of the genetic architecture of SCA phenotypic variability. Two single nucleotide polymorphisms in the intronic region of 2q16.1, harboring the gene, are genome-wide and significantly associated with decreasing HbF. A set of variants was identified to nominally be associated with increasing VOC and are potential genetic modifiers harboring phenotypic variation among patients. To the best of our knowledge, this is the first investigation of clinical variation in SCA in Angola using a well-customized and targeted sequencing approach.
本研究的目的是利用下一代测序技术,在簇集区域、基因间区域以及与镰状细胞贫血(SCA)异质性表型相关的基因中鉴定遗传标记,并评估它们在安哥拉人群中的影响和患病率。考虑血液学、生化和临床数据以确定患者的严重程度表型。对192名患者的样本进行测序,共记录了5,019,378个高质量变异。生成了一个候选修饰基因目录,这些基因聚集在对SCA重要的病理生理途径中,并鉴定出与血管闭塞性危机(VOC)增加和胎儿血红蛋白(HbF)降低相关的候选基因。这些数据支持了SCA表型变异遗传结构的多基因观点。位于2q16.1内含子区域、包含该基因的两个单核苷酸多态性在全基因组范围内与HbF降低显著相关。鉴定出一组变异,它们名义上与VOC增加相关,并且是患者中具有表型变异的潜在遗传修饰因子。据我们所知,这是首次使用精心定制的靶向测序方法对安哥拉SCA的临床变异进行调查。